Centessa Pharmaceuticals plc ($CNTA)
Filing Information
| Accession Number | 0001470831-26-000090 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Feb 1, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
168,158
Total Value
$347,862.06
P&L
+inf% (+$4,167,240.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Ordinary Shares | โ | Feb 1, 2026 | Tax Withholding | 14,158 | $24.57 | $347,862.06 | 108,121 | Direct | โ | View Details | |
Chief Business Officer | Ordinary Shares | โ | Feb 2, 2026 | Grant/Award | 31,000 | $0.00 | $0.00 | 139,121 | Direct | โ | View Details | |
Chief Business Officer | Share Option (right to buy) | Derivative | Feb 2, 2026 | Grant/Award | 123,000 | $0.00 | $0.00 | 123,000 | Direct | โ | View Details |